疫苗预防癌症：能否针对内源性抗原？
Vaccine prevention of cancer: can endogenous antigens be targeted?
机构信息
Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road Northwest, Washington, DC 20057, USA.
出版信息
Cancer Prev Res (Phila). 2010 Apr;3(4):410-5. doi: 10.1158/1940-6207.CAPR-10-0040. Epub 2010 Mar 23.
Abstract
This perspective on the report by Beatty et al. in this issue of the journal (beginning on page 438) discusses the prevention of cancer through vaccination strategies that target antigens associated with tumor promotion and progression. Such approaches were first developed for treating cancer. We address cancer vaccination in the context of a mouse model of inflammatory bowel disease expressing MUC1, an epithelial mucin aberrantly expressed during chronic inflammation and in colorectal carcinogenesis, and in a broader context that includes the potential of targeting the tumor microenvironment for immunoprevention in humans. Obstacles in developing effective cancer vaccines, including antigen selection, immunoediting, and tumor-mediated immunosuppression, are also discussed.
摘要
这篇观点文章探讨了通过针对与肿瘤促进和进展相关抗原的疫苗接种策略来预防癌症。这些方法最初是为治疗癌症而开发的。我们在表达 MUC1 的炎症性肠病小鼠模型和更广泛的背景下讨论癌症疫苗接种，其中包括针对肿瘤微环境进行免疫预防的潜力。我们还讨论了开发有效癌症疫苗所面临的障碍，包括抗原选择、免疫编辑和肿瘤介导的免疫抑制。
相似文献
1
Vaccine prevention of cancer: can endogenous antigens be targeted?疫苗预防癌症：能否针对内源性抗原？
Cancer Prev Res (Phila). 2010 Apr;3(4):410-5. doi: 10.1158/1940-6207.CAPR-10-0040. Epub 2010 Mar 23.
2
Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention.非病毒致癌抗原以及驱动癌症早期发展的炎症信号作为癌症免疫预防的靶点。
Clin Cancer Res. 2015 Apr 1;21(7):1549-57. doi: 10.1158/1078-0432.CCR-14-1186. Epub 2015 Jan 26.
3
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.肿瘤相关黏蛋白 MUC1 的免疫识别是通过一种完全合成的异常糖基化 MUC1 三聚体疫苗实现的。
Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):261-6. doi: 10.1073/pnas.1115166109. Epub 2011 Dec 14.
4
The ultimate in cancer chemoprevention: cancer vaccines.癌症化学预防的终极手段：癌症疫苗。
Cancer Prev Res (Phila). 2010 Apr;3(4):406-9. doi: 10.1158/1940-6207.CAPR-10-0043. Epub 2010 Mar 23.
5
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.针对在炎症性肠病和癌症中表达的 MUC1 抗原的疫苗可减轻结肠炎症并防止其发展为与结肠炎相关的结肠癌。
Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194. Epub 2010 Mar 23.
6
Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention.用于癌症疫苗接种的通用肿瘤抗原：靶向端粒酶进行免疫预防。
Discov Med. 2007 Aug;7(39):103-8.
7
Cancer Immunoprevention: Current Status and Future Directions.癌症免疫预防：现状与未来方向。
Arch Immunol Ther Exp (Warsz). 2021 Feb 27;69(1):3. doi: 10.1007/s00005-021-00604-x.
8
Immunoprevention of Pancreatic Cancer.免疫预防胰腺癌。
Curr Med Chem. 2018;25(22):2576-2584. doi: 10.2174/0929867324666170223153509.
9
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas.通过针对异常表达的自身抗原预防癌症：MUC1 疫苗预防上皮腺癌。
Ann N Y Acad Sci. 2013 May;1284:52-6. doi: 10.1111/nyas.12108.
10
Vaccines and other immunological approaches for cancer immunoprevention.癌症免疫预防的疫苗和其他免疫方法。
Curr Drug Targets. 2011 Dec;12(13):1957-73. doi: 10.2174/138945011798184146.
引用本文的文献
1
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.肝细胞癌中癌症疫苗及疫苗策略的综合综述
Vaccines (Basel). 2023 Aug 12;11(8):1357. doi: 10.3390/vaccines11081357.
2
Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52.对致癌性肿瘤自身蛋白D52疫苗接种引发的CD8+ IL-10+ T细胞反应的分析。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1413-1423. doi: 10.1080/21645515.2019.1689746. Epub 2019 Nov 26.
3
Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention.非病毒致癌抗原以及驱动癌症早期发展的炎症信号作为癌症免疫预防的靶点。
Clin Cancer Res. 2015 Apr 1;21(7):1549-57. doi: 10.1158/1078-0432.CCR-14-1186. Epub 2015 Jan 26.
4
Overexpressed oncogenic tumor-self antigens.过度表达的致癌肿瘤自身抗原。
Hum Vaccin Immunother. 2014;10(11):3297-305. doi: 10.4161/hv.29475.
5
What is recent in pancreatic cancer immunotherapy?胰腺癌免疫治疗的新进展是什么？
Biomed Res Int. 2013;2013:492372. doi: 10.1155/2013/492372. Epub 2012 Dec 26.
6
Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.瘤内给予低剂量抗 CD40 mAb 联合单磷酰脂质 A 可在免疫功能正常和 T 细胞缺陷小鼠中诱导局部和全身抗肿瘤作用。
J Immunother. 2013 Jan;36(1):29-40. doi: 10.1097/CJI.0b013e3182780f61.
7
Future directions in cancer prevention.癌症预防的未来方向。
Nat Rev Cancer. 2012 Dec;12(12):835-48. doi: 10.1038/nrc3397. Epub 2012 Nov 15.
8
Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.慢病毒载体疫苗和痘苗病毒载体加强可产生高质量的 CD8 记忆 T 细胞，并预防自发的小鼠黑色素瘤。
J Immunol. 2011 Aug 15;187(4):1788-96. doi: 10.4049/jimmunol.1101138. Epub 2011 Jul 11.
9
Potential targets for pancreatic cancer immunotherapeutics.胰腺癌免疫治疗的潜在靶点。
Immunotherapy. 2011 Apr;3(4):517-37. doi: 10.2217/imt.11.10.
10
Stimulation of anti-tumor immunity by photodynamic therapy.光动力疗法刺激抗肿瘤免疫。
Expert Rev Clin Immunol. 2011 Jan;7(1):75-91. doi: 10.1586/eci.10.81.
本文引用的文献
1
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.针对在炎症性肠病和癌症中表达的 MUC1 抗原的疫苗可减轻结肠炎症并防止其发展为与结肠炎相关的结肠癌。
Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194. Epub 2010 Mar 23.
2
Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.非小细胞肺癌中表观遗传去抑制的癌症睾丸抗原的综合发现。
PLoS One. 2009 Dec 4;4(12):e8189. doi: 10.1371/journal.pone.0008189.
3
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.JAK2抑制剂AZD1480可有效阻断实体瘤中的Stat3信号传导和肿瘤发生。
Cancer Cell. 2009 Dec 8;16(6):487-97. doi: 10.1016/j.ccr.2009.10.015.
4
Therapeutic breast cancer vaccines: a new strategy for early-stage disease.治疗性乳腺癌疫苗：早期疾病的新策略。
BioDrugs. 2009;23(5):277-87. doi: 10.2165/11313490-000000000-00000.
5
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.癌症抗原的优先级排序：美国国立癌症研究所加速转化研究的试点项目
Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737.
6
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.美国临床肿瘤学会关于使用包括他莫昔芬、雷洛昔芬和芳香化酶抑制在内的药物干预措施降低乳腺癌风险的临床实践指南更新。
Gynecol Oncol. 2009 Oct;115(1):132-134. doi: 10.1016/j.ygyno.2009.06.006.
7
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.环氧化酶-2对结直肠癌中凋亡诱导激酶DRAK2的调控
Br J Cancer. 2009 Aug 4;101(3):483-91. doi: 10.1038/sj.bjc.6605144.
8
A systematic review of humoral immune responses against tumor antigens.针对肿瘤抗原的体液免疫反应的系统综述。
Cancer Immunol Immunother. 2009 Oct;58(10):1535-44. doi: 10.1007/s00262-009-0733-4. Epub 2009 Jun 28.
9
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.肠道微生物群的调节会改变结肠炎相关的结直肠癌易感性。
PLoS One. 2009 Jun 24;4(6):e6026. doi: 10.1371/journal.pone.0006026.
10
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.来自两项关于用西妥昔单抗进行活性细胞免疫疗法治疗晚期前列腺癌的3期随机、双盲、安慰剂对照试验的综合数据。
Cancer. 2009 Aug 15;115(16):3670-9. doi: 10.1002/cncr.24429.
Zotero 插件